Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
An update from Aoxin Q&M Dental Group Ltd. ( (SG:1D4) ) is now available.
Aoxin Q&M Dental Group Ltd. announced that its two hospitals in China have identified an excess claim of approximately RMB3.7 million in material costs under the government medical co-payment scheme for FY2024, following a self-review mandated by the National Healthcare Security Administration. This refund is expected to materially impact the company’s financials in the first half of FY2025, and shareholders are advised to trade cautiously.
More about Aoxin Q&M Dental Group Ltd.
Aoxin Q&M Dental Group Ltd., incorporated in Singapore, operates in the healthcare industry, focusing on dental services. The company manages hospitals and clinics, providing dental treatments and related services, with a market focus on leveraging government medical co-payment schemes in China.
Average Trading Volume: 111,009
Technical Sentiment Signal: Sell
Current Market Cap: S$22.51M
For a thorough assessment of 1D4 stock, go to TipRanks’ Stock Analysis page.